Complete Filing Data
ADIAL PHARMACEUTICALS, INC. reported Stockholders Equity of $5.28 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ADIAL PHARMACEUTICALS, INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$8.0M | -$13.2M | -$5.1M | -$12.7M | -$19.4M | -$10.9M | -$8.6M | -$11.6M | -$1.1M |
| Operating Expenses | $7.8M | $8.3M | $6.9M | $10.9M | $19.3M | $10.9M | $8.2M | $7.0M | $995.3K |
| Research And Development Expense | $2.6M | $3.2M | $1.3M | $2.0M | $8.4M | $5.9M | $4.0M | $368.5K | $182.1K |
| Operating Income Loss | -$7.8M | -$8.3M | -$6.9M | -$10.9M | -$19.3M | -$10.9M | -$8.2M | -$7.0M | -$995.3K |
| Nonoperating Income Expense | -$177.7K | -$4.9M | -$113.9K | $63.3K | -$228.7K | $35.0K | -$346.5K | -$4.6M | -$144.2K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$13.2M | -$7.0M | -$10.8M | -$19.5M | -$10.9M | -$8.6M | -$11.6M | -$1.1M | |
| General And Administrative Expense | $5.2M | $5.1M | $5.6M | $8.9M | $9.3M | $5.1M | $4.3M | $6.6M | $813.2K |
| Amortization Of Intangible Assets | $565.00 | $565.00 | $564.00 | $564.00 | $565.00 | $564.00 | $565.00 | $563.00 | $565.00 |
| Income Loss From Continuing Operations Per Basic Share | -$2.72 | -$4.91 | -$10.78 | ||||||
| Income Loss From Continuing Operations Per Diluted Share | -$2.72 | -$4.91 | -$10.78 | ||||||
| Income Loss From Equity Method Investments | -$492.1K | -$552.2K | -$193.9K | ||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$7.0M | -$10.8M | |||||||
| Income Loss From Continuing Operations | -$13.2M | -$7.0M | -$10.8M | ||||||
| Deferred Income Tax Liabilities Net | $23.4K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.8M | -$2.0M | -$2.2M | -$2.2M | -$2.5M | -$6.5M | -$1.4M | $1.1M | -$2.9M | -$3.1M | -$3.8M | -$2.9M | -$4.3M | -$4.4M | -$4.8M | -$3.3M | -$1.8M | -$2.3M | -$1.7M | -$2.1M | -$2.7M | -$8.2M | -$1.8M | -$379.0K | -$292.6K | -$264.3K | |
| Operating Expenses | $1.8M | $1.9M | $2.3M | $2.2M | $2.3M | $1.8M | $1.4M | $1.5M | $2.3M | $2.6M | $3.2M | $3.1M | $4.1M | $4.4M | $4.8M | $3.3M | $1.8M | $2.3M | $1.7M | $2.2M | $2.2M | $3.8M | $1.7M | $339.5K | $262.4K | $241.5K | |
| Research And Development Expense | $521.1K | $732.3K | $746.9K | $1.0M | $1.0M | $454.3K | $207.1K | $429.9K | $365.6K | $696.1K | $680.0K | $596.3K | $1.7M | $2.3M | $2.1M | $1.8M | $888.0K | $1.1M | $864.3K | $1.2M | $686.9K | $188.4K | $76.9K | $55.5K | $27.8K | $57.9K | |
| Operating Income Loss | -$1.8M | -$1.9M | -$2.3M | -$2.2M | -$2.3M | -$1.8M | -$1.4M | -$1.5M | -$2.3M | -$2.6M | -$3.2M | -$3.1M | -$4.1M | -$4.4M | -$4.8M | -$3.3M | -$1.8M | -$2.3M | -$1.7M | -$2.2M | -$2.2M | -$3.8M | -$1.7M | -$339.5K | -$262.4K | -$241.5K | |
| Nonoperating Income Expense | -$29.6K | -$75.8K | $38.5K | $19.7K | -$171.1K | -$4.6M | $10.2K | -$32.5K | $28.9K | $3.5K | $6.9K | $151.1K | -$254.3K | -$37.2K | $6.6K | $2.5K | $7.7K | $23.4K | $29.9K | $24.6K | -$433.4K | -$4.4M | -$50.9K | -$39.4K | -$30.2K | -$22.8K | |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.2M | -$2.5M | -$6.5M | -$1.3M | -$1.5M | -$2.2M | -$2.6M | -$3.2M | -$2.9M | -$4.3M | -$4.4M | -$4.8M | -$3.3M | -$1.8M | -$2.3M | -$1.7M | -$2.1M | -$2.7M | -$8.2M | -$1.8M | -$379.0K | -$292.6K | -$264.3K | ||||
| General And Administrative Expense | $1.2M | $1.2M | $1.5M | $1.2M | $1.3M | $1.4M | $1.2M | $1.0M | $1.9M | $1.9M | $2.6M | $2.5M | $2.4M | $2.1M | $2.8M | $1.5M | $930.8K | $1.2M | $881.5K | $948.6K | $1.6M | $3.6M | $1.7M | $284.0K | $160.7K | $161.2K | |
| Amortization Of Intangible Assets | $141.00 | $141.00 | $141.00 | $141.00 | $141.00 | $141.00 | $142.00 | $141.00 | |||||||||||||||||||
| Income Loss From Continuing Operations Per Basic Share | -$0.38 | -$0.59 | -$2.19 | -$1.14 | -$1.33 | -$2.12 | -$2.48 | -$3.33 | |||||||||||||||||||
| Income Loss From Continuing Operations Per Diluted Share | -$0.38 | -$0.59 | -$2.19 | -$1.14 | -$1.33 | -$2.12 | -$2.48 | ||||||||||||||||||||
| Income Loss From Equity Method Investments | -$76.9K | -$98.7K | -$163.1K | -$31.0K | -$222.5K | -$189.9K | |||||||||||||||||||||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$2.5M | -$6.5M | -$1.3M | -$1.5M | -$2.2M | -$2.6M | -$3.2M | ||||||||||||||||||||
| Income Loss From Continuing Operations | -$2.2M | -$2.2M | -$6.5M | -$1.3M | |||||||||||||||||||||||
| Deferred Income Tax Liabilities Net | $22.9K | $1.7K | $23.4K | $23.4K | $23.4K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.3M | $4.1M | $4.1M | $3.3M | $3.5M | $4.0M | $7.1M | $4.4M | -$997.6K | -$103.5K |
| Cash And Cash Equivalents At Carrying Value | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M | $3.9M | $18.2K | $88.0K | |
| Retained Earnings Accumulated Deficit | -$90.0M | -$82.0M | -$68.8M | -$63.7M | -$50.9M | -$31.5M | -$20.6M | -$12.0M | -$404.0K | |
| Prepaid Expense And Other Assets Current | $299.7K | $308.2K | $371.6K | $349.4K | $389.5K | $501.7K | $359.5K | $317.5K | $9.0K | |
| Liabilities Current | $1.4M | $975.9K | $653.1K | $1.8M | $2.7M | $1.5M | $539.1K | $258.0K | $1.0M | |
| Liabilities And Stockholders Equity | $6.7M | $5.0M | $4.7M | $5.7M | $7.5M | $5.5M | $7.7M | $4.7M | $34.5K | |
| Common Stock Value | $1.1K | $259.00 | $1.7K | $1.1K | $20.9K | $14.4K | $10.4K | $6.9K | $3.3K | |
| Assets Current | $6.2M | $4.1M | $3.2M | $4.8M | $6.5M | $5.1M | $7.7M | $4.7M | $27.2K | |
| Assets | $6.7M | $5.0M | $4.7M | $5.7M | $7.5M | $5.5M | $7.7M | $4.7M | $34.5K | |
| Accrued Liabilities Current | $741.7K | $677.5K | $477.7K | $963.3K | $2.4M | $856.6K | $348.8K | $158.3K | ||
| Accounts Payable Current | $655.2K | $250.1K | $103.3K | $276.4K | $286.2K | $648.7K | $190.2K | $99.7K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | |||||
| Finite Lived Intangible Assets Net | $5.0K | $5.6K | $6.2K | $6.7K | $7.3K | |||||
| Liabilities | $1.4M | $975.9K | $653.1K | $2.5M | $4.0M | $1.5M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $2.1M | $923.4K | -$1.2M | -$2.1M | $1.7M | -$2.4M | ||||
| Cash And Cash Equivalents Period Increase Decrease | -$2.4M | $2.9M | $3.9M | -$69.7K | ||||||
| Stock Issued During Period Value Equitybased Compensation Stock Issuances To Consultants | $218.5K | |||||||||
| Other Assets Noncurrent | $6.7K | $7.3K | ||||||||
| Other Liabilities Current | $10.4K | $9.7K | ||||||||
| Equitybased Compensation Stock Issuances To Consultants And Employees | $1.3M | $2.0M | ||||||||
| Equity Method Investments | $489.7K | $981.8K | $1.5M | |||||||
| Property Plant And Equipment Net | $58.1K | |||||||||
| Operating Lease Right Of Use Asset | $246.2K | |||||||||
| Goodwill | $249.0K | |||||||||
| Finance Lease Right Of Use Asset Amortization | $52.2K | $48.1K | ||||||||
| Finance Lease Liability Current | $49.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $4.5M | $5.6M | $2.1M | $5.9M | $4.3M | $6.1M | $2.3M | $3.3M | $1.4M | $5.4M | $8.0M | $10.7M | $7.2M | $4.8M | $5.6M | $7.1M | $8.8M | $5.6M | $8.7M | $10.1M | $11.7M | $4.9M | -$1.3M | -$1.3M | ||||
| Cash And Cash Equivalents At Carrying Value | $4.6M | $5.9M | $2.4M | $5.2M | $3.3M | $5.0M | $315.9K | $1.2M | $2.3M | $5.8M | $9.2M | $12.7M | $7.2M | $5.2M | $5.6M | $7.4M | $8.6M | $5.0M | $6.8M | $8.5M | $10.3M | $11.4M | $4.8M | $150.0K | $54.0K | $40.4K | $137.1K | |
| Retained Earnings Accumulated Deficit | -$88.0M | -$86.2M | -$84.2M | -$79.9M | -$77.7M | -$75.3M | -$66.9M | -$65.5M | -$66.6M | -$60.8M | -$57.7M | -$53.9M | -$45.1M | -$40.8M | -$36.4M | -$28.1M | -$24.7M | -$22.9M | -$18.6M | -$16.9M | -$14.7M | -$10.8M | -$2.6M | |||||
| Prepaid Expense And Other Assets Current | $407.5K | $163.6K | $263.4K | $409.8K | $188.6K | $275.4K | $469.6K | $91.4K | $223.4K | $504.1K | $194.1K | $265.9K | $569.8K | $147.1K | $297.5K | $592.8K | $176.8K | $240.4K | $510.9K | $155.2K | $279.4K | $428.6K | $30.0K | |||||
| Liabilities Current | $1.2M | $1.2M | $1.3M | $829.0K | $671.9K | $562.7K | $528.2K | $461.8K | $1.8M | $1.3M | $1.9M | $2.2M | $2.0M | $2.2M | $2.0M | $1.1M | $681.9K | $389.8K | $776.9K | $626.6K | $329.2K | $322.8K | $1.5M | |||||
| Liabilities And Stockholders Equity | $5.7M | $6.8M | $3.5M | $6.7M | $4.9M | $6.7M | $2.9M | $3.8M | $3.9M | $7.7M | $10.9M | $14.0M | $10.4M | $8.1M | $8.6M | $8.2M | $9.5M | $5.9M | $9.5M | $10.7M | $12.1M | $5.3M | $187.1K | |||||
| Common Stock Value | $23.8K | $21.5K | $6.7K | $6.4K | $4.3K | $4.1K | $1.2K | $1.2K | $28.5K | $26.9K | $25.9K | $23.7K | $20.4K | $18.4K | $17.3K | $14.2K | $13.4K | $10.6K | $10.3K | $10.2K | $10.2K | $6.6K | $3.6K | |||||
| Assets Current | $5.0M | $6.1M | $2.6M | $5.6M | $3.8M | $5.3M | $1.1M | $2.0M | $3.0M | $6.8M | $9.9M | $13.0M | $8.0M | $5.6M | $6.2M | $8.2M | $9.5M | $5.9M | $9.5M | $10.7M | $12.1M | $5.2M | $180.1K | |||||
| Assets | $5.7M | $6.8M | $3.5M | $6.7M | $4.9M | $6.7M | $2.9M | $3.8M | $3.9M | $7.7M | $10.9M | $14.0M | $10.4M | $8.1M | $8.6M | $8.2M | $9.5M | $5.9M | $9.5M | $10.7M | $12.1M | $5.3M | $187.1K | |||||
| Accrued Liabilities Current | $598.5K | $539.9K | $758.7K | $500.9K | $335.2K | $375.3K | $408.6K | $324.4K | $1.2M | $955.4K | $1.0M | $1.7M | $1.7M | $1.7M | $1.3M | $845.6K | $239.5K | $193.4K | ||||||||||
| Accounts Payable Current | $556.3K | $671.1K | $532.4K | $318.1K | $316.7K | $81.9K | $111.7K | $530.1K | $278.2K | $617.8K | $415.1K | $185.2K | $477.4K | $637.4K | $247.4K | $442.4K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.6M | $5.9M | $2.4M | $5.2M | $3.3M | $5.0M | $315.9K | $1.2M | $2.3M | $5.8M | $9.2M | $12.7M | ||||||||||||||||
| Finite Lived Intangible Assets Net | $4.3K | $4.5K | $4.6K | $4.8K | $4.9K | $5.2K | $5.3K | $5.5K | $5.7K | $5.9K | $6.0K | $6.3K | $6.5K | $6.6K | $6.9K | $7.0K | ||||||||||||
| Liabilities | $1.2M | $1.2M | $1.3M | $829.0K | $671.9K | $562.7K | $528.2K | $461.8K | $2.5M | $2.3M | $3.0M | $3.3M | $3.2M | $3.2M | $3.0M | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$1.4M | $2.2M | -$1.7M | $6.6M | $1.2M | -$1.8M | ||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$1.8M | $7.5M | $35.7K | |||||||||||||||||||||||||
| Stock Issued During Period Value Equitybased Compensation Stock Issuances To Consultants | $548.1K | $275.0K | $850.9K | $329.8K | $9.8K | $345.6K | $71.3K | $154.3K | $154.9K | |||||||||||||||||||
| Other Assets Noncurrent | $5.7K | $5.9K | $6.0K | $6.2K | $6.3K | $6.5K | $6.6K | $6.9K | $7.0K | |||||||||||||||||||
| Other Liabilities Current | $7.6K | $5.6K | $3.6K | $8.4K | $11.9K | $9.9K | ||||||||||||||||||||||
| Equitybased Compensation Stock Issuances To Consultants And Employees | $62.1K | $79.1K | $473.9K | $416.4K | $548.1K | $275.0K | $850.9K | |||||||||||||||||||||
| Equity Method Investments | $643.1K | $720.0K | $818.7K | $1.1M | $1.1M | $1.3M | $1.7M | $1.7M | ||||||||||||||||||||
| Property Plant And Equipment Net | $48.5K | $50.4K | $52.4K | $54.3K | $56.2K | $62.0K | $62.0K | $30.2K | ||||||||||||||||||||
| Operating Lease Right Of Use Asset | $180.2K | $194.0K | $207.5K | $220.7K | $233.6K | $258.6K | $270.7K | $282.6K | ||||||||||||||||||||
| Goodwill | $249.0K | $249.0K | $249.0K | $249.0K | $249.0K | $131.5K | $131.5K | $131.5K | ||||||||||||||||||||
| Finance Lease Right Of Use Asset Amortization | $13.8K | $12.6K | $11.7K | |||||||||||||||||||||||||
| Finance Lease Liability Current | $58.8K | $56.8K | $55.0K | $53.1K | $51.4K | $47.8K | $46.1K | $44.4K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow * | -$6.5M | -$6.9M | -$6.8M | -$11.2M | -$11.9M | -$7.6M | -$6.3M | -$2.5M | -$494.9K |
| Share Based Compensation | $676.2K | $796.8K | $1.7M | $3.4M | $4.2M | $2.0M | $1.6M | $5.4M | $205.4K |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $344.5K | $597.5K | $1.2M | $1.1M | $251.9K | ||||
| Net Cash Provided By Used In Financing Activities | $8.5M | $7.8M | $4.1M | $9.1M | $13.6M | $5.6M | $9.2M | $6.3M | $390.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$8.6K | -$63.4K | $22.2K | -$40.1K | -$112.2K | $142.2K | $42.0K | $308.5K | -$9.7K |
| Increase Decrease In Accrued Liabilities | $100.3K | $199.7K | -$485.6K | -$1.4M | $1.5M | $458.5K | $190.5K | $155.7K | |
| Proceeds From Warrant Exercises | $4.8M | $3.8M | $503.00 | $1.9K | $1.4M | $450.0K | $1.1M | $156.3K | |
| Increase Decrease In Accounts Payable | -$183.5K | $15.8K | -$353.8K | $624.8K | $90.5K | ||||
| Proceeds From Issuance Of Common Stock | $3.7M | $4.0M | $749.9K | $9.1M | $11.8M | $5.2M | |||
| Stock Issued During Period Value Share Based Compensation | $1.2M | $2.1M | $2.3M | $1.4M | $1.1M | ||||
| Increase Decrease In Prepaid Expense | $418.8K | -$223.1K | $303.9K | $31.0K | $506.0K | ||||
| Net Cash Provided By Used In Investing Activities | $150.0K | $1.5M | -$34.0K | -$350.0K | $35.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow * | -$1.6M | -$1.6M | -$2.3M | -$2.5M | -$2.8M | -$1.8M | -$1.7M | -$214.3K | ||||||||||||||||||
| Share Based Compensation | $236.7K | $226.0K | $459.6K | $983.6K | $843.3K | $1.3M | $395.5K | $570.6K | $384.9K | $284.0K | $3.5M | $1.5M | $69.2K | $73.9K | $22.4K | |||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $88.0K | $75.1K | $93.3K | $136.4K | $153.4K | $177.0K | $293.7K | $310.3K | $397.4K | $477.9K | $625.8K | $567.2K | $640.8K | $568.3K | $473.8K | $348.2K | $385.6K | $342.0K | $313.6K | $310.2K | $129.2K | $31.8K | $69.6K | $69.2K | ||
| Net Cash Provided By Used In Financing Activities | $50.6K | $3.8M | $609.6K | $9.1M | $4.1M | $9.2M | $250.0K | |||||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$44.8K | -$96.2K | -$126.1K | -$123.6K | -$204.2K | -$119.1K | -$38.1K | |||||||||||||||||||
| Increase Decrease In Accrued Liabilities | $81.2K | -$102.5K | $183.7K | -$682.1K | $474.8K | -$38.4K | $110.6K | |||||||||||||||||||
| Proceeds From Warrant Exercises | $3.8M | $1.4M | $1.1M | |||||||||||||||||||||||
| Increase Decrease In Accounts Payable | $282.3K | $74.1K | $86.4K | $129.1K | -$12.2K | $6.2K | -$39.4K | |||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $50.6K | $609.6K | $9.1M | $2.6M | $500.0K | |||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $95.4K | $49.0K | $143.4K | $51.9K | $49.0K | $310.3K | $397.4K | $477.9K | $625.8K | $567.2K | $640.8K | $568.3K | $473.8K | |||||||||||||
| Increase Decrease In Prepaid Expense | $3.8K | $206.3K | $294.1K | -$126.3K | ||||||||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $150.0K | -$286.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$11.93 | -$68.01 | -$3.60 | -$12.71 | -$1.04 | -$0.87 | -$0.87 | -$2.44 | -$0.35 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 1.1M | 258.8K | 1.7M | 1.1M | 20.9M | 14.4M | 10.4M | 6.9M | 3.3M |
| Common Stock Shares Issued | 1.1M | 258.8K | 1.7M | 1.1M | 20.9M | 14.4M | 10.4M | 6.9M | 3.3M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 18.6M | 12.5M | 9.9M | 4.8M | 3.3M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 668.6K | 194.1K | 1.4M | 1.0M | 18.6M | ||||
| Earnings Per Share Basic | $-11.93 | $-68.01 | $-3.60 | $-12.71 | $-1.04 | ||||
| Weighted Average Number Of Shares Issued Basic | 4.9M | 1.4M | 1.0M | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 668.6K | 194.1K | 25.0M | 18.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.08 | -$0.18 | -$0.34 | -$0.38 | -$0.59 | -$2.19 | -$1.18 | $0.96 | -$2.75 | -$3.02 | -$3.96 | -$0.13 | -$0.22 | -$0.25 | -$0.30 | -$0.24 | -$0.16 | -$0.22 | -$0.17 | -$0.21 | -$0.33 | -$1.48 | -$0.50 | -$0.12 | -$0.09 | -$0.08 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 23.8M | 21.5M | 6.6M | 6.4M | 4.3M | 4.1M | 1.2M | 1.2M | 28.5M | 26.9M | 25.9M | 23.7M | 20.4M | 18.4M | 17.3M | 14.2M | 13.4M | 10.6M | 10.3M | 10.2M | 10.2M | 6.6M | 3.6M | |||
| Common Stock Shares Issued | 23.8M | 21.5M | 6.6M | 6.4M | 4.3M | 4.1M | 1.2M | 1.2M | 28.5M | 26.9M | 25.9M | 23.7M | 20.4M | 18.4M | 17.3M | 14.2M | 13.4M | 10.6M | 10.3M | 10.2M | 10.2M | 6.6M | 3.6M | |||
| Common Stock Shares Authorized | 100.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 19.8M | 17.6M | 15.9M | 13.6M | 11.3M | 10.5M | 10.3M | 10.2M | 8.3M | 5.5M | 3.6M | 3.3M | 3.3M | 3.3M | ||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 22.2M | 10.6M | 6.5M | 5.8M | 4.2M | 3.0M | 1.2M | 1.1M | 1.1M | 1.0M | 972.6K | 23.2M | 19.8M | 17.6M | ||||||||||||
| Earnings Per Share Basic | $-0.08 | $-0.18 | $-0.34 | $-0.38 | $-0.59 | $-2.19 | $-1.18 | $0.96 | $-2.75 | $-3.02 | $-3.96 | $-0.13 | $-0.22 | $-0.25 | ||||||||||||
| Weighted Average Number Of Shares Issued Basic | 10.6M | 6.5M | 5.8M | 4.2M | 3.0M | 1.2M | 1.1M | 1.1M | 1.0M | 972.6K | ||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 22.2M | 5.8M | 26.5M | 25.7M | 24.3M | 23.2M | 19.8M | 17.6M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $149.6K | $178.7K | $69.8K | $63.3K | $6.5K | $32.5K | $95.2K | $7.4K | $367.00 |
| Additional Paid In Capital | $95.2M | $86.1M | $72.9M | $66.9M | $54.4M | $35.5M | $27.8M | $16.5M | -$596.8K |
| Other Prepaid Expense Current | $9.9K | $233.0K | $536.9K | $506.0K | |||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $9.1M | $11.8M | $559.8K | $1.1M | $1.1M | ||||
| Stock Issued During Period Value Other | $75.0K | $51.9K | $11.8M | $1.5M | |||||
| Other Depreciation And Amortization | $564.00 | $564.00 | $6.5K | ||||||
| Gain Loss On Derivative Instruments Net Pretax | $522.0K | -$281.7K | |||||||
| Unrealized Gain Loss On Derivatives | -$193.9K | $522.0K | -$281.7K | ||||||
| Other Income | $46.5K | $2.5K | |||||||
| Stock Issued During Period Value Issued For Services | $367.8K | $199.4K | $2.0M | $710.8K | $523.7K | ||||
| Stock Issued During Period Value Exercise Of Warrents | $450.0K | $1.1M | $156.3K | ||||||
| Stock Issued During Period Value New Issues | $3.7M | $4.0M | $749.9K | ||||||
| Stock Issued During Period Value Stock Options Exercised | $4.8M | $3.8M | $503.00 | $1.9K | $469.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $47.9K | $23.7K | $35.3K | $50.7K | $51.4K | $22.8K | $10.2K | $19.4K | $28.9K | $3.5K | $6.9K | $2.9K | $1.2K | $295.00 | $2.5K | $5.2K | $23.4K | $29.9K | $24.6K | $8.4K | $38.00 | ||||
| Additional Paid In Capital | $92.5M | $91.8M | $86.3M | $85.8M | $82.0M | $81.4M | $69.2M | $68.8M | $68.0M | $66.2M | $65.6M | $64.5M | $52.3M | $45.6M | $42.0M | $35.1M | $33.5M | $28.4M | $27.3M | $26.9M | $26.4M | $15.7M | $1.3M | ||
| Other Prepaid Expense Current | $428.7K | $428.7K | $516.5K | $588.9K | $9.9K | $235.5K | $233.0K | $236.9K | $214.4K | $668.5K | $743.2K | $460.1K | $271.7K | $379.7K | |||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $9.1M | $5.5M | $2.8M | $2.6M | $1.1M | ||||||||||||||||||||
| Stock Issued During Period Value Other | $411.1K | $49.0K | $51.9K | $5.5M | $2.8M | $2.6M | $500.0K | $4.7M | $1.5M | ||||||||||||||||
| Other Depreciation And Amortization | $1.9K | $1.9K | $662.00 | ||||||||||||||||||||||
| Gain Loss On Derivative Instruments Net Pretax | -$14.0K | $75.0K | -$24.0K | $146.0K | -$274.5K | -$67.5K | $6.3K | ||||||||||||||||||
| Unrealized Gain Loss On Derivatives | -$14.0K | $146.0K | $6.3K | ||||||||||||||||||||||
| Other Income | $28.9K | $5.1K | $17.4K | $29.1K | $295.00 | $2.5K | |||||||||||||||||||
| Stock Issued During Period Value Issued For Services | $49.5K | $427.3K | $62.1K | $79.1K | $473.9K | $416.4K | |||||||||||||||||||
| Stock Issued During Period Value Exercise Of Warrents | $450.0K | $178.00 | $26.00 | $1.1M | |||||||||||||||||||||
| Stock Issued During Period Value New Issues | $477.6K | $3.1M | $50.6K | $3.6M | $411.1K | $4.5M | $140.3K | $609.6K | $4.7M | ||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $47.0K | $2.2M | $3.8M | $58.00 | $14.5K |
Most recent annual filing with the SEC: March 5, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.